{"type":"rich","provider_url":"https://hatena.blog","provider_name":"Hatena Blog","url":"https://general-id.hatenablog.com/entry/2019/09/13/222516","categories":["\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6","\u4e88\u9632","\u30a6\u30a4\u30eb\u30b9"],"published":"2019-09-13 22:25:16","title":"\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u30ef\u30af\u30c1\u30f3\u682a 2019-2020","author_url":"https://blog.hatena.ne.jp/General-ID/","description":"\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u30ef\u30af\u30c1\u30f3\u682a 2019-2020 \uff081\uff09WHO\u306e\u63a8\u5968 21 February 2019 (updated on 21 March 2019) It is recommended that egg based quadrivalent vaccines for use in the 2019-2020 northern hemisphere influenza season contain the following: A/Brisbane/02/2018 (H1N1)pdm09-like virus; A/Kansas/14/2017 (H3N2)-like virus; * B/\u2026","author_name":"General-ID","width":"100%","blog_url":"https://general-id.hatenablog.com/","blog_title":"General-ID\u306e\u30d6\u30ed\u30b0","height":"190","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fgeneral-id.hatenablog.com%2Fentry%2F2019%2F09%2F13%2F222516\" title=\"\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u30ef\u30af\u30c1\u30f3\u682a 2019-2020 - General-ID\u306e\u30d6\u30ed\u30b0\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","version":"1.0","image_url":null}